FDA DEVICE FACTS
JLK-NCCT
JLK, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
JLK-NCCT is a radiological computer-aided triage and notification software designed for analyzing non-contrast head CT (NCCT) images. The software assists hospital networks and trained clinicians by flagging and communicating them of findings suggestive of (1) Intracranial Hemorrhage (ICH) and (2) large vessel occlusion (LVO) involving the internal carotid artery (ICA), middle cerebral artery M1 (MCA-M1) and middle cerebral artery M2 (MCA-M2) on NCCT images. JLK-NCCT employs an artificial intelligence (AI) algorithm to analyze images and highlight cases with detected (1) ICH or (2) LVO on an on-premises or cloud-based JLK server. This occurs in parallel with the ongoing standard of care image interpretation. Users receive notifications for cases with suspected ICH and LVO findings via mobile devices. Notifications include compressed preview images for informational purposes only and not intended for diagnostic use beyond notification. The device does not modify the original medical image, and is not intended to be used as a primary diagnostic device. The results of JLK-NCCT are intended to be used in conjunction with other patient information and professional judgment to assist with triage and prioritization of medical images. Clinicians who receive notifications are responsible for reviewing full images per the standard of care. JLK-NCCT is intended for adults use only. Limitations and warnings:
- All patients should receive appropriate care, including a CT angiography (CTA) and/or relevant treatments as part of the standard stroke workup. The device is not intended to rule out any medical conditions, therefore, cases without a “Suspected ICH” or “Suspected LVO” notification should not be assumed to exclude ICH or LVO. All cases should undergo a CTA as part of the standard stroke workup.
- The device does not replace the need for CTA or MRA in ischemic stroke workup, it provides workflow prioritization and notification only. Contraindications/Exclusions:
- Patient Motion: excessive motion leading to artifacts that make the scan technically inadequate.
- Hemorrhagic Transformation
- Very thin or no Ventricles
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。